Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.
The U.S. Food and Drug Administration has granted approval to Sandoz’s Hyrimoz (adalimumab-adaz), a biosimilar to Abbvie’s Humira. FDA approval includes indications for seven diseases, including juvenile idiopathic arthritis for ... Read more
Pin It on Pinterest